MAI Capital Management’s AbbVie ABBV Stock Holding History

MAI Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$32K	–	801
2021 Q1	$32K	Buy	+300	New	+$32.1K	﹤0.01%	725
2019 Q4	–	Sell	-8,100	Closed	-$613K	–	592
2019 Q3	$613K	Hold	8,100	–	–	0.03%	324
2019 Q2	$589K	Hold	8,100	–	–	0.03%	329
2019 Q1	$653K	Buy	+8,100	New	+$663K	0.03%	269

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MAI Capital Management's ABBV Position: Q2 2026 in Review

MAI Capital Management increased its AbbVie (ABBV) stake by 6.8% in Q2 2026, buying an estimated $8.41M and bringing the position to 616,940 shares worth $155M. The position accounts for 0.58% of the portfolio, ranked #34.

MAI Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MAI Capital Management held 616,940 shares of AbbVie worth $155M as of Q2 2026.
MAI Capital Management bought 39,107 AbbVie shares in Q2 2026, an estimated $8.41M.
AbbVie made up 0.58% of MAI Capital Management's portfolio in Q2 2026, its #34 holding.
MAI Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.